驱动基因路径:根据MutSigCV和统计方法,识别癌症中的驱动基因和驱动路径
Xiaolu Xu1, Zitong Qi2, Dawei Zhang1
1School of Computer and Information Technology, Liaoning Normal University, Dalian 116029, China.
Computational and structural biotechnology journal
|June 9, 2023
概括
一个新的R包,DriverGenePathway,通过整合MutSigCV和统计方法来识别癌症驱动基因和途径. 它为癌症研究提供了更好的一致性和可操作性.
科学领域:
- 计算生物学是一种计算生物学.
- 癌症基因组学 癌症基因组学
- 生物信息学是一种生物信息学.
背景情况:
- 现有的识别癌症驱动基因的计算方法在研究中缺乏一致性和稳定性.
- 对于驱动基因识别,需要使用者友好的工具,改进操作性和系统兼容性.
研究的目的:
- 开发一个用户友好的R包,DriverGenePathway,用于识别癌症驱动基因和途径.
- 为了提高准确性,将 MutSigCV 等既定方法与新型的统计方法相结合.
主要方法:
- 开发了DriverGenePathway R包,将MutSigCV的理论基础和信息用于突变类别的发现.
- 采用了五种假设测试方法 (β-二项式,费舍尔,概率比,卷积,投影) 来识别核心驱动基因.
- 引入了新的方法来解决驱动路径识别的突变异质.
主要成果:
- 证明了DriverGenePathway在八种TCGA癌症类型上的表现.
- 成功证实已知的驱动基因,与癌症基因普查名单有很高的重叠.
- 确定了对癌症发展至关重要的重要驱动路径.
结论:
- 驱动GenePathway为癌症驱动基因和途径识别提供了一个强大的和用户友好的平台.
- 该套餐提高了驱动基因发现的一致性和稳定性,有助于癌症研究.
- 驱动程序GenePathway在GitHub上免费提供,为研究社区促进可访问性.
相关概念视频
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402